Market by Component (Storage, Transportation, Monitoring components), Pharma Type (Branded Drugs, Generic Drugs, OTC), Therapy Area (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Other Therapy Areas), Logistics Type (Non-Cold Chain Logistics, Cold Chain Logistics) and Regional Outlook | Forecast 2024-2032
According to Triton Market Research’s report, the Global Pharmaceutical Logistics Market is estimated to advance with a CAGR of 7.67% during the forecast period 2024-2032. The pharmaceutical logistics market size was $94856.53 million in 2023 and is expected to reach a revenue of $185139.34 million by 2032.
PHARMACEUTICAL LOGISTICS MARKET SCOPE
Report scope can be customized per your requirements - Request Free Sample Report
PHARMACEUTICAL LOGISTICS MARKET ANALYSIS
The pharmaceutical logistics industry has witnessed significant growth due to increasing demand for pharmaceutical logistics services. Key players in this market include pharmaceutical logistics companies and 3PL providers. These companies offer services such as transportation, warehousing, and distribution of pharmaceutical products. Pharmaceutical cold chain logistics is crucial, ensuring the safe and effective delivery of temperature-sensitive medications and biological products.
Effective logistics management is essential for timely product delivery, inventory management, and regulatory compliance. Companies are adopting advanced technologies like real-time tracking, data analytics, and automation to streamline operations and enhance supply chain visibility. Advanced supply chain pharmaceutical logistics providers specialize in managing the supply chain for pharmaceutical companies, offering customized solutions tailored to their specific needs. These services include order management, shipment consolidation, and reverse logistics.
PHARMACEUTICAL LOGISTICS MARKET PERFORMANCE: DRIVERS, CHALLENGES, AND OPPORTUNITIES
Meeting Rising Demand Via Pharmaceutical Logistics
The pharmaceutical logistics market is largely supported by the escalating demand for temperature-regulated solutions to maintain the quality and efficacy of drugs, particularly biologics and mRNA substances, during manufacturing and distribution. The COVID-19 pandemic significantly drove this demand, with the rapid rollout of mRNA vaccines necessitating robust cold chain logistics and cryogenic labeling capabilities. Companies like DHL are investing heavily in expanding their temperature-controlled facilities and infrastructure. For instance, as per a press release by DHL in February 2023, DHL Global Forwarding invested $8.0 million in a new 40,000-square-foot warehouse in North Carolina, US, offering multiple temperature-controlled chambers for cold-chain products.
Additionally, increased ocean freight services as a cost-effective and environmentally friendly alternative to air transport for non-temperature-sensitive pharmaceuticals support the market’s development. Ocean freight aligns with corporate sustainability goals by reducing carbon footprints, although air freight remains crucial for time-sensitive shipments. Besides, the increasing consumer preference for over-the-counter (OTC) medications is another driver. Major pharmaceutical companies are shifting focus towards OTC drug production, forming partnerships and joint ventures to expand their OTC portfolios, consequently boosting demand for pharmaceutical logistics solutions.
Tackling Transparency, Compliance, and Operational Challenges through Pharma Logistics
A major challenge in the market is the necessity for real-time transparency and reliability, which is crucial for tracking products, identifying supply chain inefficiencies, meeting regulatory requirements, and maintaining quality. However, achieving these goals is hindered by the complexity of supply chains, technical limitations, and the need for cooperation and data sharing among stakeholders.
Another significant hurdle is the stringent regulatory mandates to ensure the safety and integrity of drugs during distribution. As per assessments from different industry associations and institutes, pharmaceutical manufacturers may encounter a damage rate of up to 30% due to logistical challenges. Approximately 25% of vaccines suffer degradation during transportation due to improper handling, while around 20% of temperature-sensitive goods face disruptions in the cold chain. A survey conducted in 2020 comprising 200 pharmaceutical manufacturers and distributors revealed that over a quarter of these entities reported instances of inventory damage, spoilage, or loss. Complying with Good Distribution Practices (GDP) guidelines, such as validating warehouses and transportation routes, conducting laboratory testing, assigning responsible personnel, and maintaining specific storage conditions based on drug formulations, poses operational and cost challenges for logistics providers.
Overcoming these challenges requires substantial investment in technology, robust processes, skilled personnel, and strong collaboration among all parties in the pharmaceutical supply chain to achieve real-time visibility, reliability, and regulatory compliance.
Embracing Advanced Therapies, Digital Transformation, and Global Expansion in Pharma Logistics
The studied market is witnessing rising opportunities in cell and gene therapy logistics, supported by the increasing global demand for advanced therapies. Major pharmaceutical companies are actively investing and pursuing mergers & acquisitions in this space, spurring the need for specialized logistics services catering to cryogenic shipments and stringent handling requirements. Leading logistics providers like AmerisourceBergen and CRYOPDP are well-positioned to address these challenges.
Additionally, companies are leveraging technologies such as cloud computing, AI, IoT, and knowledge graphs to enhance supply chain visibility, efficiency, and security. Digital solutions enable counterfeit prevention, regulatory compliance, cost optimization, and seamless collaboration with suppliers and distributors.
Furthermore, the growing demand for clinical trial logistics presents new possibilities. The increasing focus on personalized medicine and direct-to-patient models necessitates integrated and patient-centric logistics solutions. Major clinical research organizations like Parexel and AmerisourceBergen are expanding their clinical trial supply capabilities to meet this demand, particularly in emerging markets like Asia-Pacific.
Based on an article published by Pharmaceutical Outsourcing, approximately 31% of global clinical trials are purportedly carried out beyond the borders of the United States, with 25% of new drug applications (NDAs) incorporating data from international locations. The most substantial growth in annual average for clinical trials between 2005 and 2012 was observed in Asian regions (30%) and Latin American/Caribbean regions (12%).
GLOBAL PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION:
• Market by Component:
o Storage
• Warehouse
• Refrigerated Containers
o Transportation
• Overland Logistics
• Sea Freight Logistics
• Air Freight Logistics
o Monitoring components
• Hardware
o Sensors
o RFID Devices
o Telematics
o Networking devices
• Software
• Market by Pharma Type:
o Branded Drugs
o Generic Drugs
o OTC
Branded drugs have high margins for manufacturers but lower margins for wholesalers and pharmacies. They are favored in some markets due to relationships with doctors and better reimbursement despite higher costs. Generic manufacturers capture significant generic drug expenditure, whereas branded manufacturers secure substantial prescription drug spending. When patents expire, generics can be filed via Abbreviated New Drug Applications (ANDAs), which are increasing. Over-the-counter (OTC) medicine usage surged during COVID-19, leading to increased reliance on pharmacists and demand for OTC products.
• Market by Therapy Area:
o Communicable Diseases
o Oncology
o Diabetes
o Cardiovascular Diseases
o Autoimmune Diseases
o Neurological Disorders
o Pain Management
o Respiratory Diseases
o Other Therapy Areas
• Market by Logistics Type:
o Non-Cold Chain Logistics
o Cold Chain Logistics
Non-Cold Chain Logistics in Pharma deals with storing and moving meds not needing temp control, like many OTC drugs and generics. It is vital for temperature-sensitive pharmaceuticals, ensuring meds like vaccines stay effective by maintaining low temperature throughout handling.
MARKET BY REGION:
• North America: United States and Canada
• Europe: United Kingdom, France, Germany, Spain, Italy, the Netherlands and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand, and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Saudi Arabia, Turkey, South Africa, and Rest of Middle East & Africa
KEY PHARMACEUTICAL LOGISTICS COMPANIES INSIGHTS
The companies’ insights help dive into data about the key players in the pharmaceutical logistics market. The strategic initiatives for each of the companies considered have been covered in detail. Some of the key strategic initiatives are:
Business Expansions & Divestitures (February 2024): FedEx Express
FedEx Express (FedEx) expanded its footprint in the Middle East with its new Middle East, Indian Subcontinent and Africa (MEISA) state-of-the-art hub at Dubai World Central (DWC) Airport in Dubai South.
Acquisitions & Mergers (March 2024): Kuehne+Nagel
Kuehne+Nagel acquired City Zone Express, a subsidiary of Chasen Holdings Ltd, a Singapore-based company. City Zone Express, founded in 2006, operates in Malaysia, Singapore, Vietnam, Thailand, and China, with over 500 employees. The acquisition will enhance Kuehne+Nagel’s cross-border road logistics services in Asia.
KEY BENEFITS OF THE REPORT:
Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.
Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.
The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.
The scope of the market report comprises the current scenario of the global pharmaceutical logistics market, along with the detailed overview of the industry outlook, market dynamics, segmentation analysis, regional outlook, and competitive landscape for the period 2024-2032.
FAQs:
Q 1) Which is the fastest-growing pharma type in the pharmaceutical logistics market?
Generic drugs are the fastest-growing pharma type in the pharmaceutical logistics market.
Q 2) Which logistics type comprises the highest share in the pharmaceutical logistics market?
Non-cold chain logistics comprises the highest market share in the market.
Q3) What is the projected market revenue of the pharmaceutical logistics market?
The pharmaceutical logistics market is anticipated to generate a revenue of $185.14 billion by 2032.
Q4) Which years does the pharmaceutical logistics market cover, and what was the market value in 2023?
In 2023, the pharmaceutical logistics market was valued at $94.86 billion. Our report explores the historical data of the pharmaceutical logistics market for the years 2020, 2021, 2022, and 2023. Additionally, the report provides a forecast of the market size from 2024 to 2032, with 2023 as the base year.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
PHARMACEUTICAL LOGISTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL LOGISTICS MARKET
2.1.1. IMPACT
OF COVID-19
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. KEY
BUYING IMPACT ANALYSIS
2.3.1. LOGISTICS
TYPE
2.3.2. SERVICES
OFFERED
2.3.3. MODE
OF TRANSPORTATION
2.3.4. APPLICATION
2.3.5. REGULATORY
COMPLIANCE
2.3.6. TECHNOLOGICAL
CAPABILITIES
2.3.7. COST
2.3.8. RELIABILITY
2.3.9. AGILITY
2.4. VALUE
CHAIN ANALYSIS
2.4.1. MANUFACTURING
2.4.2. STORAGE
2.4.3. TRANSPORTATION
2.4.4. DISTRIBUTION
2.4.5. MONITORING
COMPONENTS
2.4.6. CONSUMPTION
2.5. REGULATORY
OUTLOOK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. KEY
MARKET STRATEGIES
2.7.1. CONTRACTS
& PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. PRODUCT
LAUNCHES & DEVELOPMENTS
2.8. MARKET
DRIVERS
2.8.1. ESCALATING
DEMAND FOR TEMPERATURE-REGULATED SOLUTIONS
2.8.2. EXPANDING
OCEAN FREIGHT SERVICES
2.8.3. INCREASING
CONSUMER INCLINATION TOWARDS OVER-THE-COUNTER MEDICATIONS
2.8.4. BOOST
IN PHARMACEUTICAL LOGISTICS DUE TO COVID-19 PANDEMIC
2.9. MARKET
CHALLENGES
2.9.1. NECESSITY
FOR REAL-TIME TRANSPARENCY AND DEPENDABILITY
2.9.2. STRINGENT
REGULATORY MANDATES
2.10. MARKET
OPPORTUNITIES
2.10.1. RISING
OPPORTUNITIES IN CELL & GENE THERAPY LOGISTICS DUE TO INCREASED DEMAND
2.10.2. DIGITAL
TRANSFORMATION PAVING THE WAY FOR ADVANCEMENTS IN PHARMACEUTICAL LOGISTICS
2.10.3. GROWING
DEMAND FOR CLINICAL TRIAL LOGISTICS
2.11. ANALYST
PERSPECTIVE
3. GLOBAL
PHARMACEUTICAL LOGISTICS MARKET - BY COMPONENT
3.1. STORAGE
3.1.1. WAREHOUSE
3.1.2. REFRIGERATED
CONTAINERS
3.2. TRANSPORTATION
3.2.1. OVERLAND
LOGISTICS
3.2.2. SEA
FREIGHT LOGISTICS
3.2.3. AIR
FREIGHT LOGISTICS
3.3. MONITORING
COMPONENTS
3.3.1. HARDWARE
3.3.1.1. SENSORS
3.3.1.2. RFID
DEVICES
3.3.1.3. TELEMATICS
3.3.1.4. NETWORKING
DEVICES
3.3.2. SOFTWARE
4. GLOBAL
PHARMACEUTICAL LOGISTICS MARKET - BY PHARMA TYPE
4.1. BRANDED
DRUGS
4.2. GENERIC
DRUGS
4.3. OTC
5. GLOBAL
PHARMACEUTICAL LOGISTICS MARKET - BY LOGISTICS TYPE
5.1. NON-COLD
CHAIN LOGISTICS
5.2. COLD
CHAIN LOGISTICS
6. GLOBAL
PHARMACEUTICAL LOGISTICS MARKET - BY THERAPY AREA
6.1. COMMUNICABLE
DISEASES
6.2. ONCOLOGY
6.3. DIABETES
6.4. CARDIOVASCULAR
DISEASES
6.5. AUTOIMMUNE
DISEASES
6.6. NEUROLOGICAL
DISORDERS
6.7. PAIN
MANAGEMENT
6.8. RESPIRATORY
DISEASES
6.9. OTHER
THERAPY AREAS
7. GLOBAL
PHARMACEUTICAL LOGISTICS MARKET – BY REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY COMPONENT
7.1.2. MARKET
BY PHARMA TYPE
7.1.3. MARKET
BY LOGISTICS TYPE
7.1.4. MARKET
BY THERAPY AREA
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.1.1. UNITED
STATES PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.1.5.2. CANADA
7.1.5.2.1. CANADA
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2. EUROPE
7.2.1. MARKET
BY COMPONENT
7.2.2. MARKET
BY PHARMA TYPE
7.2.3. MARKET
BY LOGISTICS TYPE
7.2.4. MARKET
BY THERAPY AREA
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. GERMANY
7.2.5.1.1. GERMANY
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2.5.2. UNITED
KINGDOM
7.2.5.2.1. UNITED
KINGDOM PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2.5.3. FRANCE
7.2.5.3.1. FRANCE
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2.5.4. ITALY
7.2.5.4.1. ITALY
MARKET FORECAST & PROSPECTS
7.2.5.5. SPAIN
7.2.5.5.1. SPAIN
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2.5.6. THE NETHERLANDS
7.2.5.6.1. THE NETHERLANDS
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2.5.7. REST
OF EUROPE
7.2.5.7.1. REST
OF EUROPE PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY COMPONENT
7.3.2. MARKET
BY PHARMA TYPE
7.3.3. MARKET
BY LOGISTICS TYPE
7.3.4. MARKET
BY THERAPY AREA
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.1.1. CHINA
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3.5.2. JAPAN
7.3.5.2.1. JAPAN
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3.5.3. INDIA
7.3.5.3.1. INDIA
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3.5.4. ASEAN
COUNTRIES
7.3.5.4.1. ASEAN
COUNTRIES PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3.5.5. AUSTRALIA
& NEW ZEALAND
7.3.5.5.1. AUSTRALIA
& NEW ZEALAND PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3.5.6. SOUTH
KOREA
7.3.5.6.1. SOUTH
KOREA PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3.5.7. REST
OF ASIA-PACIFIC
7.3.5.7.1. REST
OF ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.4. LATIN
AMERICA
7.4.1. MARKET
BY COMPONENT
7.4.2. MARKET
BY PHARMA TYPE
7.4.3. MARKET
BY LOGISTICS TYPE
7.4.4. MARKET
BY THERAPY AREA
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. BRAZIL
7.4.5.1.1. BRAZIL
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.4.5.2. MEXICO
7.4.5.2.1. MEXICO
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.4.5.3. REST
OF LATIN AMERICA
7.4.5.3.1. REST
OF LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY COMPONENT
7.5.2. MARKET
BY PHARMA TYPE
7.5.3. MARKET
BY LOGISTICS TYPE
7.5.4. MARKET
BY THERAPY AREA
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. TURKEY
7.5.5.1.1. TURKEY
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.5.5.2. SAUDI
ARABIA
7.5.5.2.1. SAUDI
ARABIA PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.5.5.3. UNITED
ARAB EMIRATES
7.5.5.3.1. UNITED
ARAB EMIRATES PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.5.5.4. SOUTH
AFRICA
7.5.5.4.1. SOUTH
AFRICA PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.5.5.5. REST
OF MIDDLE EAST & AFRICA
7.5.5.5.1. REST
OF MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET FORECAST &
PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. AGILITY
LOGISTICS
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. AP
MOLLER – MAERSK
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. CARDINAL
HEALTH INC
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. CENCORA
(AMERISOURCEBERGEN)
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. CEVA
LOGISTICS
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. DB
SCHENKER
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. DEUTSCHE
POST AG
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. DSV
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. FEDEX
CORPORATION
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. KUEHNE
+ NAGEL
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. MARKEN
(ACQUIRED BY UPS)
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY
STRENGTHS
8.11.4. 8KEY
CHALLENGES
8.12. MEDLINE
INDUSTRIES LP
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. SEKO
LOGISTICS
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
8.14. UNITED
PARCEL SERVICE (UPS)
8.14.1. OVERVIEW
8.14.2. PORTFOLIO
8.14.3. KEY
STRENGTHS
8.14.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL PHARMACEUTICAL
LOGISTICS MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $
MILLION)
TABLE 2: GLOBAL PHARMACEUTICAL
LOGISTICS MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 3: LIST OF CONTRACTS &
PARTNERSHIPS
TABLE 4: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS
& MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 7: GLOBAL PHARMACEUTICAL
LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL PHARMACEUTICAL
LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
TABLE 9: GLOBAL PHARMACEUTICAL
LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $
MILLION)
TABLE 11: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)
TABLE 12: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $ MILLION)
TABLE 13: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $ MILLION)
TABLE 14: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $ MILLION)
TABLE 15: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS,
2020-2023 (IN $ MILLION)
TABLE 16: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032
(IN $ MILLION)
TABLE 17: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 18: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 19: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $ MILLION)
TABLE 20: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $ MILLION)
TABLE 21: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $ MILLION)
TABLE 22: EUROPE
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 23: EUROPE
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 24: EUROPE
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $ MILLION)
TABLE 25: EUROPE
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $ MILLION)
TABLE 26: EUROPE
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $ MILLION)
TABLE 32: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 33: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 34: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $ MILLION)
TABLE 35: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $ MILLION)
TABLE 36: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
TABLE 38: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 39: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $
MILLION)
TABLE 40: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $
MILLION)
TABLE 41: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $
MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: VALUE CHAIN ANALYSIS
FIGURE 4: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2023 & 2032 (IN %)
FIGURE 5: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 6: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY WAREHOUSE, 2024-2032 (IN $ MILLION)
FIGURE 7: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY REFRIGERATED CONTAINERS, 2024-2032 (IN $
MILLION)
FIGURE 8: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 9: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY OVERLAND LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 10: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY SEA FREIGHT LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 11: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY AIR FREIGHT LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 12: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $
MILLION)
FIGURE 13: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)
FIGURE 14: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY SENSORS, 2024-2032 (IN $ MILLION)
FIGURE 15: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY RFID DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 16: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY TELEMATICS, 2024-2032 (IN $ MILLION)
FIGURE 17: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY NETWORKING DEVICES, 2024-2032 (IN $
MILLION)
FIGURE 18: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)
FIGURE 19: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2023 & 2032 (IN %)
FIGURE 20: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 21: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 22: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 23: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2023 & 2032 (IN %)
FIGURE 24: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 25: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 26: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2023 & 2032 (IN %)
FIGURE 27: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 28: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 29: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 30: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 31: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 32: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $
MILLION)
FIGURE 33: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 34: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 35: GLOBAL
PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $
MILLION)
FIGURE 36: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 37: UNITED STATES
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 38: CANADA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 39: EUROPE
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 40: GERMANY
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 41: UNITED KINGDOM
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 42: FRANCE
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 43: ITALY
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 44: SPAIN
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 45: REST OF EUROPE
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 46: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 47: CHINA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 48: JAPAN
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 49: INDIA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 50: ASEAN COUNTRIES
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 51: AUSTRALIA & NEW
ZEALAND PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 52: SOUTH KOREA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 53: REST OF
ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 54: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 55: BRAZIL
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 56: MEXICO
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 57: REST OF LATIN
AMERICA PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 58: MIDDLE EAST &
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN
%)
FIGURE 59: TURKEY
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 60: SAUDI ARABIA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 61: UNITED ARAB
EMIRATES PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 62: SOUTH AFRICA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 63: REST OF MIDDLE EAST
& AFRICA PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)